A lack of awareness pertaining to fertility in people of the young generation and women opting for fertility treatment is likely to increase fertility duration and, in due course, may need in-vitro fertilization, thereby fueling the demand for assisted reproductive technology. Infertility is a multi-faceted issue involving social, cultural, and economic implications, which may reach threatening extents in nations with having problems with demographics. According to statistics published by WHO, about 8.0%-10.0% of couples are suffering from a certain type of infertility issue.
The research offers a bird’s eye view of the current market scenario regarding the operations of the leading companies in the Assistive Reproductive Technology market. The Assistive Reproductive Technology report presents an extensive analysis of the leading players with regards to their business portfolio, product portfolio, market share and size, global reach and position, revenue share, gross profit margins, and production and manufacturing capacity.
To get holistic SAMPLE of the report, please click: https://www.emergenresearch.com/request-sample/165
The crucial information covered by the report offers the readers and businesses a way to capitalize on the current market scenario and enables a strategic business decision-making process for improved profitability. Some of the key players of the market analyzed in the report to offer a better understanding of the competitive landscape are as follows.
Key participants include Origio, Cryolab Ltd., Bloom IVF Center, Ferring Pharmaceuticals, Cosmos Biomedical, Irvine Scientific, European Sperm Bank, Ovascience, Parallabs, and Microm UK Ltd., among others.
To get an Inquiry About Report: https://www.emergenresearch.com/purchase-enquiry/165
Regional Scope- North America; Europe; Asia Pacific; Central & South America; MEA
Emergen Research has segmented the global assisted reproductive technology market on the basis of procedure, technology, end-users, and region:
- Procedure Outlook (Revenue, USD Billion; 2017-2027)
- Fresh Donor
- Fresh Non-Donor
- Frozen Donor
- Frozen Non-Donor
- Egg/Embryo Banking
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- In-Vitro Fertilization (IVF)
- In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
- In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)
- Artificial Insemination-Intrauterine (AI-IUI)
- Frozen Embryo Transfer (FET)
- Others
- In-Vitro Fertilization (IVF)
- End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Hospitals
- Fertility Clinics
- Others
Request a customized copy of report:
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Assisted Reproductive Technology Market Segmentation & Impact Analysis
4.1. Assisted Reproductive Technology Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Growing prevalence of ovulation problem
4.2.2.2. Growing awareness and social adoption of assisted reproductive technology
4.2.2.3. Surge in infertility rate
4.2.2.4. Rising number of single women
4.2.3. Market restraints analysis
4.2.3.1. Stringent regulatory norms
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Assisted Reproductive Technology Market By Procedure Insights & Trends, Revenue (USD Million)
5.1. Procedure Dynamics & Market Share, 2019 & 2027
5.1.1. Fresh Donor
5.1.2. Fresh Non-Donor
5.1.3. Frozen Donor
5.1.4. Frozen Non-Donor
5.1.5. Egg/Embryo Banking
Chapter 6. Assisted Reproductive Technology Market By Technology Insights & Trends Revenue (USD Million)
6.1. Technology Dynamics & Market Share, 2019 & 2027
6.1.1. In-Vitro Fertilization (IVF)
6.1.1.1. In-Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
6.1.1.2. In-Vitro Fertilization (IVF) without Intracytoplasmic Sperm Injection (ICSI)
6.1.2. Artificial Insemination-Intrauterine (AI-IUI)
6.1.3. Frozen Embryo Transfer (FET)
6.1.4. Others
Continue..!
Read more About Assistive Reproductive Technology Industry Report: https://www.emergenresearch.com/industry-report/assistive-reproductive-technology-market
Thank you for reading our report. For further details or to inquire about customization, please let us know, and we will offer you a report well-suited to your requirements.
Related Report:
Immunotherapy Drugs Market@ https://www.google.com.nf/url?q=https://www.emergenresearch.com/industry-report/immunotherapy-drugs-market
IoT Integration Market@ https://www.google.no/url?q=https://www.emergenresearch.com/industry-report/iot-integration-market
Progressive Web Application Market@ https://www.google.com.om/url?q=https://www.emergenresearch.com/industry-report/progressive-web-application-market
Calcite Market@ https://www.google.com.pk/url?q=https://www.emergenresearch.com/industry-report/calcite-market
Biological Wastewater Treatment Market@ https://www.google.ps/url?q=https://www.emergenresearch.com/industry-report/biological-wastewater-treatment
Healthcare Supply Chain Management Market@ https://www.google.com.pa/url?q=https://www.emergenresearch.com/industry-report/healthcare-supply-chain-management-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
